Optimizing targeted cancer therapies and medication adherence

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to understand how targeted anticancer drugs behave in the body and how patients adhere to their medication regimens. It includes an observational component to analyze drug concentration and its effects, as well as an interventional component focused on improving adherence to oral targeted therapies. By identifying factors that influence drug levels and adherence, the study seeks to tailor treatment plans to individual patient needs, potentially enhancing efficacy and reducing toxicity. The findings could lead to more personalized cancer treatment strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cancer patients to whom a targeted anticancer therapy is prescribed

Exclusion Criteria:

* Patients incapable of judgment or participants under tutelage

Where it's running

• Chuv
  Lausanne, Canton of Vaud, Switzerland Recruiting

Study contacts

• Principal investigator: Chantal Csajka, PharmD, PhD — Clinical Pharmacy Sciences
• Study coordinator: Chantal Csajka, PharmD, PhD
• Email: chantal.csajka@chuv.ch
• Phone: 21 314 42 63

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized rehabilitation to preserve swallowing after organ-preserving robotic RESA surgery

  This program will try a 12-week intensive, customized speech, swallowing, and voice rehabilitation for people having minimally invasive robotic RESA surgery for head and neck cancer to help preserve swallowing.

  Recruiting Centre Hospitalier Universitaire Vaudois · Lausanne · NCT07546045

• SwissNeuroRehab HDHI — High-Dose, High-Intensity Stroke Rehabilitation Program

  This program tests whether a structured, device-supported high-dose, high-intensity therapy plan can improve motor recovery for adults with subacute or chronic stroke across inpatient, outpatient, and home settings in Switzerland.

  Recruiting at 3 sites Centre Hospitalier Universitaire Vaudois · Vitznau, Canton of Lucerne and 4 other locations · NCT07427511

• Trimipramine with atezolizumab and bevacizumab for recurrent glioblastoma

  Researchers will try whether adding the antidepressant trimipramine to the immunotherapy atezolizumab plus bevacizumab helps people with recurrent glioblastoma.

  Recruiting at 7 sites Phase 2 Centre Hospitalier Universitaire Vaudois · Basel, Basel and 6 other locations · NCT07263438

• Mentalization-Based Treatment for young people at clinical high risk for psychosis

  This project will test whether adding Mentalization-Based Treatment to usual need-based clinical care helps young people (ages 14–30) at high risk for psychosis reduce symptoms and avoid developing full psychosis.

  Recruiting Centre Hospitalier Universitaire Vaudois · Lausanne · NCT07093671

• Adaptive cognitive exergame to help cognitive problems in MS

  This study tests whether computer-based, game-like brain training can help adults with relapsing or early secondary progressive MS who have cognitive difficulties.

  Recruiting Centre Hospitalier Universitaire Vaudois · Lausanne, Canton of Vaud · NCT07086950

• Automated glucose control's effect on kidney health in diabetes

  This study is testing if a new automated way to control blood sugar can improve kidney health in adults with type 2 diabetes and early kidney disease.

  Recruiting Centre Hospitalier Universitaire Vaudois · Lausanne, Canton of Vaud and 1 other locations · NCT06925217

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.